young, young pete: a shot of jacksonville beach, florida. the fourth and final hour of this saturday edition of fox & friends. january 6th. year of our lord, 2024. looks like a nice spot. kayleigh: that s where i was born, jacksonville, florida. home to tim tebow. pete: you know the name of the hospital. kayleigh: st. vincent hospital. will: what s the name of your hospital? pete: i don t know. i know i was born in minneapoli- kayleigh: mama s going to text you. pete: probably a lutheran hospital in minneapolis. will: i was surprised you were surprise anded she knew pete: the name of the hospital. will: lynn, do you know the name of the hospital you were born in? everyone knows. you re the outlier. kayleigh: maybe you re just maintaining your private. pete: i ve been hipaa from the beginning. will: maybe you were found in a basket. [laughter] kayleigh: like moses. pete: moses down the minehaha river there in minnesota. [laughter] kayleigh: oh, my if goodness. pete: by t
Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.
Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment.
Experts in multiple myeloma discuss highlights from the ASH 2023 meeting around transplant-eligible NDMM with particular focus on the PERSEUS and GRIFFIN trials and the clinical implications of the results of these studies.